Skip to Main Content

Paper Details

Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications.
J Pathol
65
2019
EGFR, MBC, MBCs, Metaplastic breast carcinoma, NF1, NF1 mutations, PIK3CA, PTEN, PTEN mutations, TP53, breast cancer, breast cancers, cancer, cytokeratin, invasive carcinomas, mesenchymal elements, metaplastic breast cancer, mixed-type tumours, neurofibromatosis, neurofibromatosis-1, pan-cytokeratin, pan-cytokeratin AE1/3 antibody, patients, primary tumours, rhabdomyoid, spindle, tumour
Author NameAffiliation
Katia NonesQIMR Berghofer Medical Research Institute
Katia NonesQIMR Berghofer Medical Research Institute
Mark BettingtonUQ Centre for Clinical Research, The University of Queensland
Mark BettingtonUQ Centre for Clinical Research, The University of Queensland
John V PearsonQIMR Berghofer Medical Research Institute
John V PearsonQIMR Berghofer Medical Research Institute
Peter T SimpsonUQ Centre for Clinical Research, The University of Queensland
Peter T SimpsonUQ Centre for Clinical Research, The University of Queensland
Nicola WaddellQIMR Berghofer Medical Research Institute
Nicola WaddellQIMR Berghofer Medical Research Institute
Sunil R LakhaniUQ Centre for Clinical Research, The University of Queensland
Sunil R LakhaniThe Royal Brisbane & Women's Hospital
Sunil R LakhaniUQ Centre for Clinical Research, The University of Queensland
Sunil R LakhaniThe Royal Brisbane & Women's Hospital
  • 1 - 14

Datasets

Release 1.2